Tag: Partners

We Challenge You! Join the Melanoma Research Alliance and the Your Cancer Game Plan Challenge!

By Cody R. Barnett, MRA Director of Communications | 31 January 2018 In Allies & Partnerships

We’re excited to announce that we’ve joined Merck on the Your Cancer Game Plan Challenge, a social sharing program that will help us raise funds and continue our support of melanoma patients, caregivers, healthcare providers and others.

Read More


MRA Raises Millions of Dollars for Groundbreaking Melanoma Research

By Cody R. Barnett, MRA Director of Communications | 5 November 2017 In Allies & Partnerships, Events

Normally, when people are at a Sotheby’s auction, they come to bid on beautiful and rare art. On Nov. 2nd, however, more than 240 people came together at Sotheby’s Headquarters in New York City to raise their paddle in the fight against melanoma. Together, participants raised over $20 million to further advance melanoma research.

Read More


Safe and Sound: Balancing Safety with Innovation in American Sunscreens

By Cody R. Barnett, MRA Director of Communications | 10 October 2017 In Allies & Partnerships, Policy, Prevention

Currently, Americans have access to 16 sunscreen active ingredients approved by the Food and Drug Administration (FDA) to prevent skin cancer. The last time a new OTC (Over the Counter) sunscreen ingredient was added to the FDA sunscreen monograph was 1999. Meanwhile, Europeans have access to 29 sunscreen active ingredients. In the United States there are currently eight new sunscreen ingredients that are pending FDA review, which have been used in Europe – many for over ten years. These new, and potentially better, active ingredients could allow sunscreens to last longer and provide better full spectrum coverage that could help us reverse trends of increasing melanoma incidence in this country. Unlike in Europe where sunscreens are classified as cosmetics, in the United States the FDA is required to evaluate all active ingredients in sunscreens as OTC drugs. Meaning, that all U.S. sunscreen ingredients must be found generally recognized as safe and effective (GRASE) in the same manner as other OTC medications. The FDA says that this is critical to keeping us safe, but is it possible to balance innovation and safety?

Read More


Melanoma Research Alliance and the American Cancer Society Forge Research Partnership to Maximize Immunotherapy Benefit to Patients

By Pamela Goldsmith, MRA Director of Communications | 10 July 2017 In Allies & Partnerships, Science

The Melanoma Research Alliance (MRA) and the American Cancer Society (ACS) are partnering to fund much-needed research aimed at decreasing rare, but serious, side effects associated with checkpoint inhibitors in hopes of increasing further cancer immunotherapy benefit to patients.

Read More


MAC: A Valued Partner in the Fight Against Melanoma

By Michael Kaplan, MRA President & CEO | 10 July 2017 In Allies & Partnerships

What do you do after the melanoma diagnosis has settled in and you’ve done all you can to ensure the best health outcome for yourself? Or even worse, what do you do after you’ve lost a spouse or a child to melanoma? For the members of the Melanoma Action Coalition, the answer is clear. You take that fear or sorrow, and you mobilize.

Read More


Melanoma Research Alliance Welcomes New Chief Development Officer

By Pamela Goldsmith, MRA Director of Communications | 10 July 2017 In News

Following 22 years of fundraising and management experience in healthcare, higher education and NPOs, Joan Russo is joining the Melanoma Research Alliance (MRA) as Chief Development Officer.

Read More


LFFM Fundraising Event Again Reaches a Record Setting Year

By Pamela Goldsmith, MRA Director of Communications | 6 June 2017 In Allies & Partnerships, Events

Nearly 1,000 professionals from the leveraged finance community gathered for the sixth annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party raising a record $1.8 million in funds for the Melanoma Research Alliance (MRA), the largest private funder of melanoma research.

Read More


MRA and BJ’s Wholesale Club Partner to Launch May Campaign

By Pamela Goldsmith, MRA Director of Communications | 3 April 2017 In Allies & Partnerships, Prevention

In today’s dynamic research environment, working as a team is more valuable than ever. This May, in an effort to spotlight Melanoma Awareness month, BJ’s Wholesale Club, a warehouse club operating in 15 states and headquartered in Massachusetts, will launch its first awareness campaign in partnership with MRA to highlight the importance of prevention.

Read More


Finance Industry Rallies to Fight Melanoma

By Rachel Gazzerro, MRA Associate Director, Development & Information Management | 3 April 2017 In Allies & Partnerships, Events

Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event, sponsored annually in New York City by the Melanoma Research Alliance (MRA) has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities – all gathered together in response to melanoma.

Read More


Spotlight on MRA’s Ninth Annual Scientific Retreat

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 February 2017 In Allies & Partnerships, Events, Science

In mid-February, MRA held its premiere research event — the 9th Annual Scientific Retreat, in Washington, DC. A total of 297 individuals registered for the meeting representing a spectrum of key stakeholders in melanoma including academic investigators, pharmaceutical and biotech company representatives, melanoma advocates from various different non-profit organizations, donors and government officials.

Read More


Login

×